Keros Therapeutics is a biotechnology company dedicated to the discovery and development of novel therapeutics for neuromuscular diseases. The Company's first program is focused on the inhibition of activin receptor-like kinase-2 (ALK2), a human protein that is the genetic driver for FOP; its second program is focused on treatments to strengthen muscle and improve function in multiple muscle disorders.
|Employees (est.) (Nov 2019)||19|
Keros Therapeutics total Funding
Keros Therapeutics latest funding size
Time since last funding
|10 months ago|
Keros Therapeutics investors
|Pontifax, Partners Innovation Fund, Arkin Bio Ventures, Global health sciences venture fund, Medison Pharma|
When was Keros Therapeutics founded?
Keros Therapeutics was founded in 2015.
How many employees does Keros Therapeutics have?
Keros Therapeutics has 19 employees.
Who are Keros Therapeutics competitors?
Competitors of Keros Therapeutics include Strand Therapeutics, Actuate Therapeutics and Imara.
Where is Keros Therapeutics headquarters?
Keros Therapeutics headquarters is located at 215 First St #500, Cambridge.
Where are Keros Therapeutics offices?
Keros Therapeutics has an office in Cambridge.
How many offices does Keros Therapeutics have?
Keros Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies